Cargando…
Plasma Lactate Dehydrogenase Levels Predict Mortality in Acute Aortic Syndromes: A Diagnostic Accuracy and Observational Outcome Study
In acute aortic syndromes (AAS), organ malperfusion represents a key event impacting both on diagnosis and outcome. Increased levels of plasma lactate dehydrogenase (LDH), a biomarker of malperfusion, have been reported in AAS, but the performance of LDH for the diagnosis of AAS and the relation of...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753927/ https://www.ncbi.nlm.nih.gov/pubmed/26871831 http://dx.doi.org/10.1097/MD.0000000000002776 |
_version_ | 1782415941644058624 |
---|---|
author | Morello, Fulvio Ravetti, Anna Nazerian, Peiman Liedl, Giovanni Veglio, Maria Grazia Battista, Stefania Vanni, Simone Pivetta, Emanuele Montrucchio, Giuseppe Mengozzi, Giulio Rinaldi, Mauro Moiraghi, Corrado Lupia, Enrico |
author_facet | Morello, Fulvio Ravetti, Anna Nazerian, Peiman Liedl, Giovanni Veglio, Maria Grazia Battista, Stefania Vanni, Simone Pivetta, Emanuele Montrucchio, Giuseppe Mengozzi, Giulio Rinaldi, Mauro Moiraghi, Corrado Lupia, Enrico |
author_sort | Morello, Fulvio |
collection | PubMed |
description | In acute aortic syndromes (AAS), organ malperfusion represents a key event impacting both on diagnosis and outcome. Increased levels of plasma lactate dehydrogenase (LDH), a biomarker of malperfusion, have been reported in AAS, but the performance of LDH for the diagnosis of AAS and the relation of LDH with outcome in AAS have not been evaluated so far. This was a bi-centric prospective diagnostic accuracy study and a cohort outcome study. From 2008 to 2014, patients from 2 Emergency Departments suspected of having AAS underwent LDH assay at presentation. A final diagnosis was obtained by aortic imaging. Patients diagnosed with AAS were followed-up for in-hospital mortality. One thousand five hundred seventy-eight consecutive patients were clinically eligible, and 999 patients were included in the study. The final diagnosis was AAS in 201 (20.1%) patients. Median LDH was 424 U/L (interquartile range [IQR] 367–557) in patients with AAS and 383 U/L (IQR 331–460) in patients with alternative diagnoses (P < 0.001). Using a cutoff of 450 U/L, the sensitivity of LDH for AAS was 44% (95% confidence interval [CI] 37–51) and the specificity was 73% (95% CI 69–76). Overall in-hospital mortality for AAS was 23.8%. Mortality was 32.6% in patients with LDH ≥ 450 U/L and 16.8% in patients with LDH < 450 U/L (P = 0.006). Following stratification according to LDH quartiles, in-hospital mortality was 12% in the first (lowest) quartile, 18.4% in the second quartile, 23.5% in the third quartile, and 38% in the fourth (highest) quartile (P = 0.01). LDH ≥ 450 U/L was further identified as an independent predictor of death in AAS both in univariate and in stepwise logistic regression analyses (odds ratio 2.28, 95% CI 1.11–4.66; P = 0.025), in addition to well-established risk markers such as advanced age and hypotension. Subgroup analysis showed excess mortality in association with LDH ≥ 450 U/L in elderly, hemodynamically stable and in nonsurgically treated patients. Plasma LDH constitutes a biomarker of poor outcome in patients with AAS. LDH is a rapid and universally available assay that could be used to improve risk stratification and to individualize treatment in patient groups where options are controversial. |
format | Online Article Text |
id | pubmed-4753927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-47539272016-02-26 Plasma Lactate Dehydrogenase Levels Predict Mortality in Acute Aortic Syndromes: A Diagnostic Accuracy and Observational Outcome Study Morello, Fulvio Ravetti, Anna Nazerian, Peiman Liedl, Giovanni Veglio, Maria Grazia Battista, Stefania Vanni, Simone Pivetta, Emanuele Montrucchio, Giuseppe Mengozzi, Giulio Rinaldi, Mauro Moiraghi, Corrado Lupia, Enrico Medicine (Baltimore) 3400 In acute aortic syndromes (AAS), organ malperfusion represents a key event impacting both on diagnosis and outcome. Increased levels of plasma lactate dehydrogenase (LDH), a biomarker of malperfusion, have been reported in AAS, but the performance of LDH for the diagnosis of AAS and the relation of LDH with outcome in AAS have not been evaluated so far. This was a bi-centric prospective diagnostic accuracy study and a cohort outcome study. From 2008 to 2014, patients from 2 Emergency Departments suspected of having AAS underwent LDH assay at presentation. A final diagnosis was obtained by aortic imaging. Patients diagnosed with AAS were followed-up for in-hospital mortality. One thousand five hundred seventy-eight consecutive patients were clinically eligible, and 999 patients were included in the study. The final diagnosis was AAS in 201 (20.1%) patients. Median LDH was 424 U/L (interquartile range [IQR] 367–557) in patients with AAS and 383 U/L (IQR 331–460) in patients with alternative diagnoses (P < 0.001). Using a cutoff of 450 U/L, the sensitivity of LDH for AAS was 44% (95% confidence interval [CI] 37–51) and the specificity was 73% (95% CI 69–76). Overall in-hospital mortality for AAS was 23.8%. Mortality was 32.6% in patients with LDH ≥ 450 U/L and 16.8% in patients with LDH < 450 U/L (P = 0.006). Following stratification according to LDH quartiles, in-hospital mortality was 12% in the first (lowest) quartile, 18.4% in the second quartile, 23.5% in the third quartile, and 38% in the fourth (highest) quartile (P = 0.01). LDH ≥ 450 U/L was further identified as an independent predictor of death in AAS both in univariate and in stepwise logistic regression analyses (odds ratio 2.28, 95% CI 1.11–4.66; P = 0.025), in addition to well-established risk markers such as advanced age and hypotension. Subgroup analysis showed excess mortality in association with LDH ≥ 450 U/L in elderly, hemodynamically stable and in nonsurgically treated patients. Plasma LDH constitutes a biomarker of poor outcome in patients with AAS. LDH is a rapid and universally available assay that could be used to improve risk stratification and to individualize treatment in patient groups where options are controversial. Wolters Kluwer Health 2016-02-12 /pmc/articles/PMC4753927/ /pubmed/26871831 http://dx.doi.org/10.1097/MD.0000000000002776 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0, where it is permissible to download, share and reproduce the work in any medium, provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | 3400 Morello, Fulvio Ravetti, Anna Nazerian, Peiman Liedl, Giovanni Veglio, Maria Grazia Battista, Stefania Vanni, Simone Pivetta, Emanuele Montrucchio, Giuseppe Mengozzi, Giulio Rinaldi, Mauro Moiraghi, Corrado Lupia, Enrico Plasma Lactate Dehydrogenase Levels Predict Mortality in Acute Aortic Syndromes: A Diagnostic Accuracy and Observational Outcome Study |
title | Plasma Lactate Dehydrogenase Levels Predict Mortality in Acute Aortic Syndromes: A Diagnostic Accuracy and Observational Outcome Study |
title_full | Plasma Lactate Dehydrogenase Levels Predict Mortality in Acute Aortic Syndromes: A Diagnostic Accuracy and Observational Outcome Study |
title_fullStr | Plasma Lactate Dehydrogenase Levels Predict Mortality in Acute Aortic Syndromes: A Diagnostic Accuracy and Observational Outcome Study |
title_full_unstemmed | Plasma Lactate Dehydrogenase Levels Predict Mortality in Acute Aortic Syndromes: A Diagnostic Accuracy and Observational Outcome Study |
title_short | Plasma Lactate Dehydrogenase Levels Predict Mortality in Acute Aortic Syndromes: A Diagnostic Accuracy and Observational Outcome Study |
title_sort | plasma lactate dehydrogenase levels predict mortality in acute aortic syndromes: a diagnostic accuracy and observational outcome study |
topic | 3400 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753927/ https://www.ncbi.nlm.nih.gov/pubmed/26871831 http://dx.doi.org/10.1097/MD.0000000000002776 |
work_keys_str_mv | AT morellofulvio plasmalactatedehydrogenaselevelspredictmortalityinacuteaorticsyndromesadiagnosticaccuracyandobservationaloutcomestudy AT ravettianna plasmalactatedehydrogenaselevelspredictmortalityinacuteaorticsyndromesadiagnosticaccuracyandobservationaloutcomestudy AT nazerianpeiman plasmalactatedehydrogenaselevelspredictmortalityinacuteaorticsyndromesadiagnosticaccuracyandobservationaloutcomestudy AT liedlgiovanni plasmalactatedehydrogenaselevelspredictmortalityinacuteaorticsyndromesadiagnosticaccuracyandobservationaloutcomestudy AT vegliomariagrazia plasmalactatedehydrogenaselevelspredictmortalityinacuteaorticsyndromesadiagnosticaccuracyandobservationaloutcomestudy AT battistastefania plasmalactatedehydrogenaselevelspredictmortalityinacuteaorticsyndromesadiagnosticaccuracyandobservationaloutcomestudy AT vannisimone plasmalactatedehydrogenaselevelspredictmortalityinacuteaorticsyndromesadiagnosticaccuracyandobservationaloutcomestudy AT pivettaemanuele plasmalactatedehydrogenaselevelspredictmortalityinacuteaorticsyndromesadiagnosticaccuracyandobservationaloutcomestudy AT montrucchiogiuseppe plasmalactatedehydrogenaselevelspredictmortalityinacuteaorticsyndromesadiagnosticaccuracyandobservationaloutcomestudy AT mengozzigiulio plasmalactatedehydrogenaselevelspredictmortalityinacuteaorticsyndromesadiagnosticaccuracyandobservationaloutcomestudy AT rinaldimauro plasmalactatedehydrogenaselevelspredictmortalityinacuteaorticsyndromesadiagnosticaccuracyandobservationaloutcomestudy AT moiraghicorrado plasmalactatedehydrogenaselevelspredictmortalityinacuteaorticsyndromesadiagnosticaccuracyandobservationaloutcomestudy AT lupiaenrico plasmalactatedehydrogenaselevelspredictmortalityinacuteaorticsyndromesadiagnosticaccuracyandobservationaloutcomestudy |